Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $890M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,000,000 | $105M | 11.8% | $25.14 | — | COM | N5749R100 |
| VERA | VERA THERAPEUTICS INC | 5,450,000 | $87.47M | 9.8% | $8.35 | +8.2% | CL A | 92337R101 |
| — | AKERO THERAPEUTICS INC | 1,675,000 | $78.21M | 8.8% | $41.36 | — | COM | 00973Y108 |
| XENE | XENON PHARMACEUTICALS INC | 1,845,000 | $71.03M | 8.0% | $26.06 | +52.5% | COM | 98420N105 |
| COGT | COGENT BIOSCIENCES INC | 5,566,026 | $65.9M | 7.4% | $8.92 | +28.6% | COM | 19240Q201 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,200,000 | $52.34M | 5.9% | $17.59 | +45.8% | COM | 92790C104 |
| — | AMBRX BIOPHARMA INC | 3,175,000 | $52.26M | 5.9% | $8.92 | — | SPONSORED ADS | 02290A102 |
| PCVX | VAXCYTE INC | 1,015,000 | $50.69M | 5.7% | $45.88 | +3.3% | COM | 92243G108 |
| NUVL | NUVALENT INC | 1,150,000 | $48.5M | 5.4% | $28.77 | +31.4% | COM | 670703107 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,348,272 | $47.93M | 5.4% | $20.30 | -0.5% | COM | 29337E102 |
| CABA | CABALETTA BIO INC | 2,368,186 | $30.57M | 3.4% | $7.26 | +49.6% | COM | 12674W109 |
| — | CYMABAY THERAPEUTICS INC | 2,025,000 | $22.17M | 2.5% | $4.40 | — | COM | 23257D103 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 610,000 | $21.75M | 2.4% | $36.28 | -5.0% | COM | 04280A100 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 631,665 | $21.43M | 2.4% | $31.07 | +8.5% | COM NEW | 15117B202 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 997,596 | $20.88M | 2.3% | $22.61 | -7.9% | COM | 87164F105 |
| IDYA | IDEAYA BIOSCIENCES INC | 775,000 | $18.21M | 2.0% | $20.56 | 0.0% | COM | 45166A102 |
| IMVT | IMMUNOVANT INC | 900,000 | $17.07M | 1.9% | $13.55 | +37.6% | COM | 45258J102 |
| — | ADVERUM BIOTECHNOLOGIES INC | 10,000,000 | $15.9M | 1.8% | $1.15 | — | COM | 00773U108 |
| CELC | CELCUITY INC | 1,444,141 | $15.86M | 1.8% | $20.00 | -48.0% | COM | 15102K100 |
| KURA | KURA ONCOLOGY INC | 1,400,000 | $14.81M | 1.7% | $13.92 | -15.0% | COM | 50127T109 |
| — | ALPINE IMMUNE SCIENCES INC | 1,325,000 | $13.62M | 1.5% | $7.20 | — | COM | 02083G100 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 739,661 | $8.832M | 1.0% | $10.33 | +26.5% | COM | 23954D109 |
| — | THIRD HARMONIC BIO INC | 993,294 | $4.778M | 0.5% | $18.97 | — | COM | 88427A107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 312,553 | $2.813M | 0.3% | $24.62 | -62.5% | COM | 483497103 |
| — | AEGLEA BIOTHERAPEUTICS INC | 2,908,100 | $1.31M | 0.1% | $0.45 | — | COM | 00773J103 |
| — | DBV TECHNOLOGIES S A | 92,687 | $176K | 0.0% | $1.53 | — | SPONSORED ADR | 23306J101 |